Format: PDF
The Global In Vitro Diagnostics (IVD) Market is calculated to reach $91.49 billion by 2024, at a CAGR of 6.01% during the forecast period 2019-2024. The rising demand for early and accurate disease diagnosis, increasing adoption of fully-automated instruments and automation in laboratories, increasing adoption of point-of-care testing, and growing awareness of personalized medicine are the key factors driving the growth of the market.
1 Global In Vitro Diagnostics (IVD) Market – Overview
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope
2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions
3 Global In Vitro Diagnostics (IVD) Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography
4 Global In Vitro Diagnostics (IVD) Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis
5 Global In Vitro Diagnostics (IVD) Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies
6 Global In Vitro Diagnostics (IVD) Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.1.1 High prevalence of chronic diseases
6.2.1.2 Increasing use of Point-of-care (POC) diagnostics
6.2.1.3 Growing awareness and acceptance of personalized medicine and companion
diagnostics
6.2.2 Challenges
6.2.2.1 Operational barriers faced in conducting diagnostic tests
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes
7 Global In Vitro Diagnostics (IVD) Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)
8 Global In Vitro Diagnostics (IVD) Market – By Product (Market Size – & million/billion)
8.1 Reagents & Kits
8.2 Instruments
8.3 Services
9 Global In Vitro Diagnostics (IVD) Market – By Technology
9.1 Immunoassay
9.2 Hematology
9.3 Clinical Chemistry
9.4 Molecular Diagnostics
9.5 Coagulation
9.6 Microbiology
9.7 Others
10 Global In Vitro Diagnostics (IVD) Market – By Application
10.1 Infectious Diseases
10.2 Diabetes
10.3 Oncology
10.4 Cardiology
10.5 Autoimmune Diseases
10.6 Nephrology
10.7 Drug Testing/Pharmacogenomics
10.8 HIV/Aids
10.9 Other
11 Global In Vitro Diagnostics (IVD) Market – By End-User
11.1 Hospitals
11.2 Laboratories
11.3 Point-Of-Care Testing
11.4 Patient Self-Testing
11.5 Academic Institutes
12 Global In Vitro Diagnostics (IVD) Market – By Geography (Market Size – & million/billion)
12.1 Introduction
12.2 North America
12.2.1 US
12.2.2 Canada
12.2.3 Mexico
12.3 Europe
12.3.1 U.K
12.3.2 Germany
12.3.3 Italy
12.3.4 France
12.3.5 Spain
12.3.6 Rest of Europe
12.4 Asia-Pacific
12.4.1 China
12.4.2 Japan
12.4.3 India
12.4.4 South Korea
12.4.5 Rest of APAC
12.5 Rest of the World
12.5.1 South America
12.5.2 Middle East
12.5.3 Africa
13 Global In Vitro Diagnostics (IVD) Market – Entropy
13.1 New product launches
13.2 M&A’s, collaborations, JVs and partnerships
14 Global In Vitro Diagnostics (IVD) Market Company Profile (Key Players)
14.1 Market Share, Company Revenue, Products, M&A, Developments
14.2 Danaher Corporation
14.3 Johnson & Johnson
14.4 Agilent Technologies
14.5 Roche Diagnostics
14.6 Becton, Dickinson and Company
14.7 Thermo Fisher Scientific
14.8 Siemens AG
14.9 Sysmex Corporation
14.10 Bio-Rad Laboratories, Inc.
14.11Qiagen
14.12 Company 11 & more
“* Private Company Financials would be provided on our best efforts”
15 Global In Vitro Diagnostics (IVD) Market – Appendix
15.1 Sources
15.2 Abbreviations
Take a look at this complimentary sample which comprises of a variety of market data points such as trend analyses, market estimates, and forecasts. You can explore and evaluate it on your own.
Send me Free SampleOr View Our License Options:
$3,850.00 – $5,850.00
Industry Coverage: Global Market Studies has a broad range of industry coverage, spanning various sectors such as healthcare, technology, retail, automotive, and many others. This means that clients can rely on us to provide valuable insights into their respective industries, helping them make informed business decisions.
Our team of experts has years of experience in the market research industry, and they have honed their skills in data analysis, market forecasting, and trend analysis. They are also adept at using advanced research tools and techniques to gather and analyze data, providing clients with accurate and reliable insights.
We understand that each client has unique research needs, and we tailor our research solutions to meet their specific requirements. We work closely with our clients to understand their objectives and provide customized research solutions that address their business challenges.
We are committed to innovation and are constantly exploring new research methods and techniques to provide our clients with cutting-edge insights. This enables us to stay ahead of the curve and deliver the best possible research outcomes.
At Global Market Studies, our clients are at the center of everything we do. We pride ourselves on providing excellent customer service and support, and we are always available to address our clients’ concerns and questions.
Accurate market data is crucial to a successful business strategy. With an 85% + accuracy in all reports, makes us one of the best and most accurate firms in the world.
Need Customized Report ?Call NowThe Global In Vitro Diagnostics (IVD) Market is calculated to reach $91.49 billion by 2024, at a CAGR of 6.01% during the forecast period 2019-2024. The rising demand for early and accurate disease diagnosis, increasing adoption of fully-automated instruments and automation in laboratories, increasing adoption of point-of-care testing, and growing awareness of personalized medicine are the key factors driving the growth of the market.
1 Global In Vitro Diagnostics (IVD) Market – Overview
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope
2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions
3 Global In Vitro Diagnostics (IVD) Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography
4 Global In Vitro Diagnostics (IVD) Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis
5 Global In Vitro Diagnostics (IVD) Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies
6 Global In Vitro Diagnostics (IVD) Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.1.1 High prevalence of chronic diseases
6.2.1.2 Increasing use of Point-of-care (POC) diagnostics
6.2.1.3 Growing awareness and acceptance of personalized medicine and companion
diagnostics
6.2.2 Challenges
6.2.2.1 Operational barriers faced in conducting diagnostic tests
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes
7 Global In Vitro Diagnostics (IVD) Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)
8 Global In Vitro Diagnostics (IVD) Market – By Product (Market Size – & million/billion)
8.1 Reagents & Kits
8.2 Instruments
8.3 Services
9 Global In Vitro Diagnostics (IVD) Market – By Technology
9.1 Immunoassay
9.2 Hematology
9.3 Clinical Chemistry
9.4 Molecular Diagnostics
9.5 Coagulation
9.6 Microbiology
9.7 Others
10 Global In Vitro Diagnostics (IVD) Market – By Application
10.1 Infectious Diseases
10.2 Diabetes
10.3 Oncology
10.4 Cardiology
10.5 Autoimmune Diseases
10.6 Nephrology
10.7 Drug Testing/Pharmacogenomics
10.8 HIV/Aids
10.9 Other
11 Global In Vitro Diagnostics (IVD) Market – By End-User
11.1 Hospitals
11.2 Laboratories
11.3 Point-Of-Care Testing
11.4 Patient Self-Testing
11.5 Academic Institutes
12 Global In Vitro Diagnostics (IVD) Market – By Geography (Market Size – & million/billion)
12.1 Introduction
12.2 North America
12.2.1 US
12.2.2 Canada
12.2.3 Mexico
12.3 Europe
12.3.1 U.K
12.3.2 Germany
12.3.3 Italy
12.3.4 France
12.3.5 Spain
12.3.6 Rest of Europe
12.4 Asia-Pacific
12.4.1 China
12.4.2 Japan
12.4.3 India
12.4.4 South Korea
12.4.5 Rest of APAC
12.5 Rest of the World
12.5.1 South America
12.5.2 Middle East
12.5.3 Africa
13 Global In Vitro Diagnostics (IVD) Market – Entropy
13.1 New product launches
13.2 M&A’s, collaborations, JVs and partnerships
14 Global In Vitro Diagnostics (IVD) Market Company Profile (Key Players)
14.1 Market Share, Company Revenue, Products, M&A, Developments
14.2 Danaher Corporation
14.3 Johnson & Johnson
14.4 Agilent Technologies
14.5 Roche Diagnostics
14.6 Becton, Dickinson and Company
14.7 Thermo Fisher Scientific
14.8 Siemens AG
14.9 Sysmex Corporation
14.10 Bio-Rad Laboratories, Inc.
14.11Qiagen
14.12 Company 11 & more
“* Private Company Financials would be provided on our best efforts”
15 Global In Vitro Diagnostics (IVD) Market – Appendix
15.1 Sources
15.2 Abbreviations
Unleashing revenue potential through strategic market research involves identifying untapped market opportunities, understanding consumer needs and preferences, and developing targeted strategies to capitalize on them. By leveraging data-driven insights, businesses can optimize product offerings, pricing strategies, and marketing efforts to drive revenue growth and stay ahead of competitors.
